SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001583648-21-000026
Filing Date
2021-05-25
Accepted
2021-05-25 08:05:02
Documents
15
Period of Report
2021-05-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pirs-20210519.htm   iXBRL 8-K 38804
2 EX-99.1 a210525gpr.htm EX-99.1 8419
6 GRAPHIC a210525gpr001.jpg GRAPHIC 327357
7 GRAPHIC a210525gpr002.jpg GRAPHIC 281321
  Complete submission text file 0001583648-21-000026.txt   1037701

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pirs-20210519.xsd EX-101.SCH 1950
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pirs-20210519_lab.xml EX-101.LAB 26285
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pirs-20210519_pre.xml EX-101.PRE 13763
8 EXTRACTED XBRL INSTANCE DOCUMENT pirs-20210519_htm.xml XML 11989
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 21957386
SIC: 2834 Pharmaceutical Preparations